Global Phase1 Study to Assess the Safety and Tolerability of AZD1208 in Advanced Solid Tumors and Malignant Lymphoma

NCT01588548 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Malignancies
Malignant Lymphoma

Interventions

DRUG: AZD1208

Sponsor

AstraZeneca